The CD44+ genotype in primary breast tumors and metastasis has been positively associated with tumor initiation and progression, metastasis and increased stemness [24], whereas CD44+/CD24- is considered a hallmark of BC stem cells. This evidence concerns the gene CD44 and neoplasm.